Remove Blogging Remove Funding Remove Layoffs Remove Technical Review
article thumbnail

Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More

Xconomy

military’s high-tech think tank DARPA described Safe Genes, a new program to fund safety measures that can be built into genome editing technology or counter its potential wayward effects. The funding could be as much as $100 million, and the first grants will be announced in 2017. —The U.S. PRICE FIGHTS.

article thumbnail

Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More

Xconomy

To boost the initiative, which aims to speed the pace of cancer research, FDA said it would consolidate its cancer review divisions under the Oncology Center of Excellence. The technology was funded by the Department of Defense and comes from MIT’s Lincoln Lab. PureTech also bucked the Brexit fallout this week.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News

Xconomy

All eyes are on Holmes, who is scheduled to present data from the company’s technology at a medical conference on August 1. million Series A to develop a drug, licensed from Columbia University, for the brain cancer glioblastoma… Lyndra , a Cambridge startup working on oral drug delivery technology, has received $5.4

News 40
article thumbnail

Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More

Xconomy

Despite technical differences and the early nature of the data that made comparison difficult, Wall Street declared Spark this week’s winner. . —More updates from the hematology meeting: Philadelphia-based Spark Therapeutics (NASDAQ: ONCE ) and Dutch firm UniQure (NASDAQ: QURE ) both updated their hemophilia B gene therapy programs.

News 55